一种具有高容量的Pluronic L64-Cupping组合,用于肌肉内基因传递
Huan Zhao1, Yuan-Yuan Zhou1, Shi-Ru Shan1
1School of Laboratory Medicine, Key Laboratory of Structure-Specific Small Molecule Drugs, Key Laboratory of Target Discovery and Protein Drug Development in Major Diseases, Chengdu Medical College, Chengdu 610500, China.
International journal of pharmaceutics
|February 16, 2025
概括
一个新的Pluronic L64-Cupping (L/C) 系统通过克服等离子体DNA (pDNA) 传递的细胞外和细胞内障碍来增强基因疗法. 这种方法可以增强基因表达并诱导抗体的产生,提供安全有效的平台.
科学领域:
- 基因治疗 基因治疗
- 生物材料科学 生物材料科学
- 分子生物学分子生物学
背景情况:
- 肌肉内等离子体DNA (pDNA) 输送面临着显著的细胞外基质 (ECM) 和细胞内障碍,限制了基因疗法的疗效.
- 现有的非病毒载体和物理方法在同时解决这些障碍方面存在局限性,导致体内基因转移不足最佳.
- 克服扩散,膜交叉,内体逃生和核向是有效基因传递的关键挑战.
研究的目的:
- 开发和评估一种新的基因传递系统,Pluronic L64-Cupping (L/C),旨在顺序克服细胞外和细胞内障碍,以增强肌肉内pDNA传递.
- 评估L/C系统在促进记者基因表达和诱导治疗性蛋白质生产中的效率.
- 为基因治疗建立一个安全,具有成本效益和临床适用的基因疗法平台.
主要方法:
- 开发了Pluronic L64-Cupping (L/C) 基因传递系统,该系统将非病毒载体与施加负压相结合.
- 用Pluronic L64复合的等离子体DNA (pDNA) 肌肉内注射,然后在注射部位施加负压.
- 评估报告者基因表达水平和注射后持续时间.
- 在小鼠模型中评估B型肝炎表面抗体 (HBsAb) 诱导.
主要成果:
- 在肌肉内注射pDNA后,L/C系统显著增强了记者基因表达.
- 持续的记者基因表达被观察到至少42天.
- 该系统有效地诱导了小鼠的HBsAb产生,证明了治疗潜力.
- 与传统方法相比,L/C系统的效率有所提高,但不会造成显著的组织损伤.
结论:
- 普鲁罗尼克L64-Cupping (L/C) 系统代表了一种新且有效的方法,用于克服肌肉内基因传递的主要障碍.
- 这种方法显著提高了基因转移效率和持续时间,为基因治疗应用提供了一个有前途的策略.
- L/C系统为研究和临床基因治疗提供了一个安全,高效和潜在的成本效益的平台.
相关概念视频
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...